How GLP-1 direct-to-consumer programs are distorting utilization trends
Closed claims no longer reflect real-world GLP-1 treatment patterns GLP-1 utilization continues to...
Know what others can’t: Real-world data gaps holding commercial teams back
The therapeutic market that you know is shaped by the healthcare data that you can see. But when critical medical, specialty, clinical or longitudinal signals are absent from that view, the picture (and the decisions based on it) is less clear. ...
GLP-1 persistence: What semaglutide data reveals about patient behavior
As the new year begins, many patients refocus on weight management and long-term health goals. At...
AI trends shaping healthcare in 2026: agentic, physical & sovereign AI
Artificial intelligence is no longer something healthcare and life sciences teams are testing on...
How the FDA is using real-world evidence in safety and approval decisions
Regulatory decision-making depends on evidence that reflects how medical products perform in...
Understanding modern ulcerative colitis through real-world data
Industry trends in ulcerative colitis research: a new path Ulcerative colitis is a chronic...
Understanding re-identification risk in PPRL
New research is challenging long-held assumptions about privacy-preserving record linkage (PPRL)....
Improving influenza decision making with multimodal vaccination and lab data
Early signals indicate continued declines in influenza vaccination uptake and shifts in the...
HCIC 2025: Data for smarter healthcare marketing
Our team had a great time at HCIC connecting with healthcare marketers, digital teams and consumer...
Accelerating real-world evidence with agentic AI
Real-world evidence (RWE) studies often stall on the same friction points: defining the most...
Veterans Day at HealthVerity: Two paths from service to impact
Veterans Day invites us to look beyond branch and rank to the people and stories behind the...